Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NVIDIA CORPNVDA · Entity 1023 | Chief Financial Officer | March 19, 2008 | March 21, 2008 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NVIDIA CORP
Report date March 19, 2008 · Filed March 21, 2008
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.66 · Expires 2014-03-19 | Direct | 75,000 |
Reported balance
After 2008-03-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2008-03-19 · Grant · Acquired 75,000 · Balance 75,000 F1: Fifty percent of the option shall vest two years and three months from March 19, 2008 which is June 19, 2010 and the remaining fifty percent shall vest two years and six months from March 19, 2008 which is September 19, 2010, such that the option shall be fully vested on the two year and six month anniversary of the grant date which is September 19, 2010. |
Filing footnotes · ownership attribution and instrument terms
F1: Fifty percent of the option shall vest two years and three months from March 19, 2008 which is June 19, 2010 and the remaining fifty percent shall vest two years and six months from March 19, 2008 which is September 19, 2010, such that the option shall be fully vested on the two year and six month anniversary of the grant date which is September 19, 2010.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ENTEGRIS INC
Report date May 24, 2017 · Filed May 26, 2017
Section 16 reporting ended · disclosed 2017-05-26. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
INTERMOLECULAR INC
Report date September 20, 2019 · Filed September 20, 2019
Section 16 reporting ended · disclosed 2019-09-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.20 | Direct | 0 |
Reported balance
After 2019-09-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-09-20 · Other · Disposed 12,500 · Balance 0 F1: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.62 | Direct | 0 |
Reported balance
After 2019-09-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-09-20 · Other · Disposed 10,000 · Balance 0 F1: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $8.21 | Direct | 0 |
Reported balance
After 2019-09-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-09-20 · Other · Disposed 10,000 · Balance 0 F1: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $2.59 | Direct | 0 |
Reported balance
After 2019-09-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-09-20 · Other · Disposed 10,000 · Balance 0 F1: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.82 | Direct | 0 |
Reported balance
After 2019-09-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-09-20 · Other · Disposed 25,000 · Balance 0 F1: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.85 | Direct | 0 |
Reported balance
After 2019-09-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-09-20 · Other · Disposed 25,000 · Balance 0 F1: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.85 | Direct | 0 |
Reported balance
After 2019-09-20 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-09-20 · Other · Disposed 25,000 · Balance 0 F1: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.39 | Direct | 0 |
Reported balance
After 2019-09-20 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-09-20 · Other · Disposed 25,000 · Balance 0 F1: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger").
F2: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger.
F3: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 20, 2019 Filed Sep 20, 2019 16:35 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherStock Option · Derivative | 25,000 | Not disclosed Strike: $1.39 | Not disclosed |
DisclosureSEC source: 0001567619-19-018606 · doc1.xml · derivative · entry 8 BURKETT MARVIN D · CIK 0001197646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · kind: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3 · price: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2 · derivative.exercise_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. F2 · derivative.expiration_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. Read SEC document |
| September 20, 2019 Filed Sep 20, 2019 16:35 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherStock Option · Derivative | 25,000 | Not disclosed Strike: $0.85 | Not disclosed |
DisclosureSEC source: 0001567619-19-018606 · doc1.xml · derivative · entry 7 BURKETT MARVIN D · CIK 0001197646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · kind: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3 · price: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2 · derivative.exercise_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. F2 · derivative.expiration_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. Read SEC document |
| September 20, 2019 Filed Sep 20, 2019 16:35 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherStock Option · Derivative | 25,000 | Not disclosed Strike: $1.85 | Not disclosed |
DisclosureSEC source: 0001567619-19-018606 · doc1.xml · derivative · entry 6 BURKETT MARVIN D · CIK 0001197646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · kind: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3 · price: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2 · derivative.exercise_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. F2 · derivative.expiration_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. Read SEC document |
| September 20, 2019 Filed Sep 20, 2019 16:35 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherStock Option · Derivative | 25,000 | Not disclosed Strike: $1.82 | Not disclosed |
DisclosureSEC source: 0001567619-19-018606 · doc1.xml · derivative · entry 5 BURKETT MARVIN D · CIK 0001197646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · kind: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3 · price: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2 · derivative.exercise_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. F2 · derivative.expiration_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. Read SEC document |
| September 20, 2019 Filed Sep 20, 2019 16:35 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherStock Option · Derivative | 10,000 | Not disclosed Strike: $2.59 | Not disclosed |
DisclosureSEC source: 0001567619-19-018606 · doc1.xml · derivative · entry 4 BURKETT MARVIN D · CIK 0001197646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · kind: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3 · price: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2 · derivative.exercise_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. F2 · derivative.expiration_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. Read SEC document |
| September 20, 2019 Filed Sep 20, 2019 16:35 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherStock Option · Derivative | 10,000 | Not disclosed Strike: $8.21 | Not disclosed |
DisclosureSEC source: 0001567619-19-018606 · doc1.xml · derivative · entry 3 BURKETT MARVIN D · CIK 0001197646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · kind: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3 · price: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2 · derivative.exercise_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. F2 · derivative.expiration_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. Read SEC document |
| September 20, 2019 Filed Sep 20, 2019 16:35 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherStock Option · Derivative | 10,000 | Not disclosed Strike: $6.62 | Not disclosed |
DisclosureSEC source: 0001567619-19-018606 · doc1.xml · derivative · entry 2 BURKETT MARVIN D · CIK 0001197646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · kind: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3 · price: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2 · derivative.exercise_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. F2 · derivative.expiration_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. Read SEC document |
| September 20, 2019 Filed Sep 20, 2019 16:35 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherStock Option · Derivative | 12,500 | Not disclosed Strike: $6.20 | Not disclosed |
DisclosureSEC source: 0001567619-19-018606 · doc1.xml · derivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires not disclosed F1 · kind: On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). F3 · price: Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option. F2 · derivative.exercise_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. F2 · derivative.expiration_date: The options are fully vested due to vesting acceleration approved by the board in connection with the Merger. Read SEC document |
| May 24, 2018 Filed May 29, 2018 18:11 UTC | INTERMOLECULAR INC IMI · Entity 154785 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001140361-18-026081 · doc1.xml · derivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-05-23 F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier to occur of (i) the first anniversary of the date of grant and (ii) the date of the annual meeting immediately following the date of grant, subject in each case to Reporting Person's continued service through the vesting date. Read SEC document |
| May 16, 2017 Filed May 24, 2017 14:52 UTC | INTERMOLECULAR INC IMI · Entity 154785 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0000899243-17-014224 · doc4.xml · derivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-05-15 F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier to occur of (i) the first anniversary of the date of grant and (ii) the date of the annual meeting immediately following the date of grant, subject in each case to Reporting Person's continued service through the vesting date. Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 22:13 UTC | ENTEGRIS INC ENTG · Entity 3271 | Exercise / conversionEmployee Stock Option (Right-to-Buy) · Derivative | 15,000 | Not disclosed Strike: $6.20 | Not disclosed |
DisclosureSEC source: 0001197646-17-000004 · edgar.xml · derivative · entry 4 BURKETT MARVIN D · CIK 0001197646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2017-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: These options were granted pursuant to a non-employee director stock option plan that provides for the grant of options in consideration of services as a director. F1 · derivative.exercise_date: This option is fully vested. Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 22:13 UTC | ENTEGRIS INC ENTG · Entity 3271 | Tax withholdingCommon Stock | 4,306 | $21.60 | $93,009.60 |
DisclosureSEC source: 0001197646-17-000004 · edgar.xml · nonDerivative · entry 2 BURKETT MARVIN D · CIK 0001197646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,429 Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 22:13 UTC | ENTEGRIS INC ENTG · Entity 3271 | Exercise / conversionCommon Stock | 15,000 | $6.20 | $93,000.00 |
DisclosureSEC source: 0001197646-17-000004 · edgar.xml · nonDerivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2008 Filed Mar 21, 2008 18:57 UTC | NVIDIA CORP NVDA · Entity 1023 | GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $17.66 | $0.00 |
DisclosureSEC source: 0001243233-08-000026 · edgar.xml · derivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2014-03-19 F1 · derivative.exercise_date: Fifty percent of the option shall vest two years and three months from March 19, 2008 which is June 19, 2010 and the remaining fifty percent shall vest two years and six months from March 19, 2008 which is September 19, 2010, such that the option shall be fully vested on the two year and six month anniversary of the grant date which is September 19, 2010. Read SEC document |
| February 19, 2008 Filed Feb 21, 2008 21:02 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionStock Option (Right to Buy) · Derivative | 11,430 | $0.00 Strike: $8.75 | $0.00 |
DisclosureSEC source: 0001243233-08-000014 · edgar.xml · derivative · entry 4 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,570 Underlying: Common Stock · 11,430 shares Expires 2010-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option was originally reported as covering 90,000 shares at an exercise price of $26.24, but was adjusted to reflect the stock splits that occurred on April 6, 2006 and September 10, 2007. Vesting begins on April 13, 2007 and continues quarterly in equal installments over the next year, fully vests on April 13, 2008. Read SEC document |
| February 19, 2008 Filed Feb 21, 2008 21:02 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6 | $0.00 Strike: $8.47 | $0.00 |
DisclosureSEC source: 0001243233-08-000014 · edgar.xml · derivative · entry 3 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,994 Underlying: Common Stock · 6 shares Expires 2011-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was originally reported as covering 100,000 shares at an exercise price of $25.42, but was adjusted to reflect the stock splits that occurred on April 6, 2006 and September 10, 2007. Vesting begins on May 17, 2007 and continues quarterly in equal installments over the next year, fully vests on May 17, 2008. Read SEC document |
| February 19, 2008 Filed Feb 21, 2008 21:02 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionCommon Stock | 11,430 | $8.75 | $100,012.50 |
DisclosureSEC source: 0001243233-08-000014 · edgar.xml · nonDerivative · entry 2 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2008 Filed Feb 21, 2008 21:02 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionCommon Stock | 6 | $8.47 | $50.82 |
DisclosureSEC source: 0001243233-08-000014 · edgar.xml · nonDerivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 538 shares of common stock acquired in an exempt transaction pursuant to NVIDIA 1998 Employee Stock Purchase Plan (Section 423). The shares reflect the 3 for 2 stock split of the Company's Common Stock on September 10, 2007. Read SEC document |
| September 19, 2007 Filed Sep 21, 2007 19:59 UTC | NVIDIA CORP NVDA · Entity 1023 | GrantStock Option (Right to Buy) · Derivative | 100,238 | $0.00 Strike: $34.36 | $0.00 |
DisclosureSEC source: 0001243233-07-000049 · edgar.xml · derivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,238 Underlying: Common Stock · 100,238 shares Expires 2013-09-19 F1 · derivative.exercise_date: 50% of the option shall vest on March 19, 2010 and 50% of the option shall vest on September 21, 2010. Read SEC document |
| April 16, 2007 Filed Apr 18, 2007 23:54 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 30,000 | $0.00 Strike: $13.12 | $0.00 |
DisclosureSEC source: 0001197646-07-000013 · edgar.xml · derivative · entry 3 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 30,000 shares Expires 2010-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: In April 13, 2004, an option to purchase 180,000 shares of common stock was granted at an exercise price of $13.12 per share. The option vests over a 4 year period with one sixth of the option vesting on January 13, 2007 with the remainder of the option vesting in equal quarterly installments. The option fully vests on April 13, 2008. Read SEC document |
| April 16, 2007 Filed Apr 18, 2007 23:54 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon Stock | 30,000 | $30.36 | $910,920.00 |
DisclosureSEC source: 0001197646-07-000013 · edgar.xml · nonDerivative · entry 2 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,617 Read SEC document |
| April 16, 2007 Filed Apr 18, 2007 23:54 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionCommon Stock | 30,000 | $13.12 | $393,600.00 |
DisclosureSEC source: 0001197646-07-000013 · edgar.xml · nonDerivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2007 Filed Mar 23, 2007 23:31 UTC | NVIDIA CORP NVDA · Entity 1023 | GrantEmployee Stock Option (Right to buy) · Derivative | 82,500 | $0.00 Strike: $28.35 | $0.00 |
DisclosureSEC source: 0001197646-07-000012 · edgar.xml · derivative · entry 2 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,500 Underlying: Common Stock · 82,500 shares Expires 2013-03-21 F1 · derivative.exercise_date: An option to purchase 82,500 shares of common stock at an exercise price of $28.35 was granted on March 21, 2007. Fifty percent of the option shall vest two years and three months from March 21, 2007 which is June 21, 2009 and the remaining fifty percent shall vest two years and six months from March 21, 2007 which is September 21, 2009, such that the option shall be fully vested on the two year and six month anniversary of the grant date which is September 21, 2009. Read SEC document |
| March 12, 2007 Filed Mar 15, 2007 00:05 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 20,616 | $0.00 Strike: $13.12 | $0.00 |
DisclosureSEC source: 0001197646-07-000011 · edgar.xml · derivative · entry 3 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 20,616 shares Expires 2010-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: In April 13, 2004, an option to purchase 180,000 shares of common stock was granted at an exercise price of $13.12 per share. The option vests over a 4 year period with one sixth of the option vesting on January 13, 2007 with the remainder of the option vesting in equal quarterly installments. The option fully vests on April 13, 2008. Read SEC document |
| March 12, 2007 Filed Mar 15, 2007 00:05 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon Stock | 20,616 | $30.31 | $624,856.53 |
DisclosureSEC source: 0001197646-07-000011 · edgar.xml · nonDerivative · entry 2 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,617 Read SEC document |
| March 12, 2007 Filed Mar 15, 2007 00:05 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionCommon Stock | 20,616 | $13.12 | $270,481.92 |
DisclosureSEC source: 0001197646-07-000011 · edgar.xml · nonDerivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2007 Filed Mar 7, 2007 02:02 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 9,384 | $0.00 Strike: $13.12 | $0.00 |
DisclosureSEC source: 0001197646-07-000010 · edgar.xml · derivative · entry 6 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,616 Underlying: Common Stock · 9,384 shares Expires 2010-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: In April 13, 2004, an option to purchase 180,000 shares of common stock was granted at an exercise price of $13.12 per share. The option vests over a 4 year period with no vesting for two and a half years from April 13, 2004, then vesting in equal quarterly installments over the next year and a half. The option fully vests in April 2008. Read SEC document |
| March 05, 2007 Filed Mar 7, 2007 02:02 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 15,616 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001197646-07-000010 · edgar.xml · derivative · entry 5 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,616 shares Expires 2012-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: In September 2002, an option to purchase 800,000 shares of common stock was granted at an exercise price of $4.74 per share. The option fully vested in September 2005. Read SEC document |
| March 05, 2007 Filed Mar 7, 2007 02:02 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon Stock | 9,384 | $29.21 | $274,087.87 |
DisclosureSEC source: 0001197646-07-000010 · edgar.xml · nonDerivative · entry 4 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,617 F3 · balance_after: Includes 537 shares acquired under NVIDIA's 1998 Employee Stock Purchase Plan (Section 423 Plan) on February 28, 2007. Read SEC document |
| March 05, 2007 Filed Mar 7, 2007 02:02 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionCommon Stock | 9,384 | $13.12 | $123,118.08 |
DisclosureSEC source: 0001197646-07-000010 · edgar.xml · nonDerivative · entry 3 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2007 Filed Mar 7, 2007 02:02 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon Stock | 15,616 | $29.21 | $456,112.13 |
DisclosureSEC source: 0001197646-07-000010 · edgar.xml · nonDerivative · entry 2 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,617 Read SEC document |
| March 05, 2007 Filed Mar 7, 2007 02:02 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionCommon Stock | 15,616 | $4.74 | $74,019.84 |
DisclosureSEC source: 0001197646-07-000010 · edgar.xml · nonDerivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2007 Filed Mar 1, 2007 01:51 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 25,000 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001197646-07-000009 · edgar.xml · derivative · entry 3 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,616 Underlying: Common Stock · 25,000 shares Expires 2012-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: In September 2002, an option to purchase 800,000 shares of common stock was granted at an exercise price of $4.74 per share. The option fully vested in September 2005. Read SEC document |
| February 26, 2007 Filed Mar 1, 2007 01:51 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon Stock | 25,000 | $32.43 | $810,767.50 |
DisclosureSEC source: 0001197646-07-000009 · edgar.xml · nonDerivative · entry 2 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,080 Read SEC document |
| February 26, 2007 Filed Mar 1, 2007 01:51 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionCommon Stock | 25,000 | $4.74 | $118,500.00 |
DisclosureSEC source: 0001197646-07-000009 · edgar.xml · nonDerivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2007 Filed Feb 22, 2007 00:54 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 25,000 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001197646-07-000008 · edgar.xml · derivative · entry 3 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,616 Underlying: Common Stock · 25,000 shares Expires 2012-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: In September 2002, an option to purchase 800,000 shares of common stock was granted at an exercise price of $4.74 per share. The option fully vested in September 2005. Read SEC document |
| February 20, 2007 Filed Feb 22, 2007 00:54 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon Stock | 25,000 | $32.92 | $823,065.00 |
DisclosureSEC source: 0001197646-07-000008 · edgar.xml · nonDerivative · entry 2 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,080 Read SEC document |
| February 20, 2007 Filed Feb 22, 2007 00:54 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionCommon Stock | 25,000 | $4.74 | $118,500.00 |
DisclosureSEC source: 0001197646-07-000008 · edgar.xml · nonDerivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2007 Filed Feb 15, 2007 01:43 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 25,000 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001197646-07-000007 · edgar.xml · derivative · entry 3 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,616 Underlying: Common Stock · 25,000 shares Expires 2012-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: In September 2002, an option to purchase 800,000 shares of common stock was granted at an exercise price of $4.74 per share. The option fully vested in September 2005. Read SEC document |
| February 12, 2007 Filed Feb 15, 2007 01:43 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon Stock | 25,000 | $33.46 | $836,595.00 |
DisclosureSEC source: 0001197646-07-000007 · edgar.xml · nonDerivative · entry 2 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,080 Read SEC document |
| February 12, 2007 Filed Feb 15, 2007 01:43 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionCommon Stock | 25,000 | $4.74 | $118,500.00 |
DisclosureSEC source: 0001197646-07-000007 · edgar.xml · nonDerivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2007 Filed Feb 8, 2007 01:33 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 25,000 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001197646-07-000006 · edgar.xml · derivative · entry 3 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,616 Underlying: Common Stock · 25,000 shares Expires 2012-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: In September 2002, an option to purchase 800,000 shares of common stock was granted at an exercise price of $4.74 per share. The option fully vested in September 2005. Read SEC document |
| February 05, 2007 Filed Feb 8, 2007 01:33 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon Stock | 25,000 | $32.43 | $810,757.50 |
DisclosureSEC source: 0001197646-07-000006 · edgar.xml · nonDerivative · entry 2 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,080 Read SEC document |
| February 05, 2007 Filed Feb 8, 2007 01:33 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionCommon Stock | 25,000 | $4.74 | $118,500.00 |
DisclosureSEC source: 0001197646-07-000006 · edgar.xml · nonDerivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:10 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 25,000 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001197646-07-000005 · edgar.xml · derivative · entry 3 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,616 Underlying: Common Stock · 25,000 shares Expires 2012-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: In September 2002, an option to purchase 800,000 shares of common stock was granted at an exercise price of $4.74 per share. The option fully vested in September 2005. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:10 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon Stock | 25,000 | $30.65 | $766,187.50 |
DisclosureSEC source: 0001197646-07-000005 · edgar.xml · nonDerivative · entry 2 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,080 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:10 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionCommon Stock | 25,000 | $4.74 | $118,500.00 |
DisclosureSEC source: 0001197646-07-000005 · edgar.xml · nonDerivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2007 Filed Jan 25, 2007 01:10 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 25,000 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001197646-07-000004 · edgar.xml · derivative · entry 3 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,616 Underlying: Common Stock · 25,000 shares Expires 2012-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: In September 2002, an option to purchase 800,000 shares of common stock was granted at an exercise price of $4.74 per share. The option fully vested in September 2005. Read SEC document |
| January 22, 2007 Filed Jan 25, 2007 01:10 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon Stock | 25,000 | $32.02 | $800,617.50 |
DisclosureSEC source: 0001197646-07-000004 · edgar.xml · nonDerivative · entry 2 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,080 Read SEC document |
| January 22, 2007 Filed Jan 25, 2007 01:10 UTC | NVIDIA CORP NVDA · Entity 1023 | Exercise / conversionCommon Stock | 25,000 | $4.74 | $118,500.00 |
DisclosureSEC source: 0001197646-07-000004 · edgar.xml · nonDerivative · entry 1 BURKETT MARVIN D · CIK 0001197646 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.